Management of patients with insomnia and polymorbidity. A draft of the clinical guidelines

Poluektov M.G.; Akarachkova E.S.; Dovgan E.V.; Kotova O.V.; Demidova T.Yu.; Klimenko A.A.; Kokorin V.A.; Ostroumova O.D.; Ostroumova T.M.

doi:https://doi.org/10.17116/jnevro202412405239

Close metadata

Recommended articles:

Stress and sleep: Neurobiological aspects and modern options of insomnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21

Factors of depression according to actigraphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32

Insomnia in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):46-51

The use of zolpidem in the treatment of acute and chronic insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):52-56

The potential of neurofeedback control in treating insomnia and improving sleep quality (a systematic review). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):57-63

Effects of rhythmic transcranial magnetic stimulation in the treatment of insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):64-69

Sleep disorders in imprinting disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):75-80

The effect of sleep and other medical and social factors on a woman’s reproductive function. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):81-86

Sleep disorders in patients with Lewy body dementia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87

The state of mental health of migrant workers and citizens of the Russian Federation: A comparative analysis as illustrated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101

Abstract:

Insomnia is a serious and widespread public health problem, but is often undetected and patients do not receive needed treatment. Insomnia is often comorbid with other diseases and conditions, such as arterial hypertension, type 2 diabetes mellitus, pain syndromes, anxiety and depressive disorders, etc. A separate problem is drug-induced insomnia, when patients develop symptoms due to other diseases treatments. Insomnia has a negative effect on the prognosis of comorbid diseases, including an increased risk of death, more severe disease, and decreased quality of life. The presence of sleep disorders makes it difficult to effectively treat the underlying disease, so clinical guidelines draft for the evaluation and treatment of insomnia in multimorbid patients is proposed. Diagnostic methods are reviewed and recommendations are given for the treatment of acute and chronic insomnia and features of the treatment of insomnia in multimorbid patients. A clinical algorithm has been proposed to determine treatment tactics in multimorbid patients.

Keywords:

sleep

sleep disorders

insomnia

polymorbidity

Authors:

Poluektov M.G.

Sechenov First Moscow State Medical University (Sechenov University)

ORCID: 0000-0001-6215-0918

Akarachkova E.S.

Medical Institute of Peoples’ Friendship University

ORCID: 0000-0002-7629-3773

Dovgan E.V.

Smolensk Regional Clinical Hospital

ORCID: 0000-0002-2655-6192

Kotova O.V.

Medical Institute of Peoples’ Friendship University;
International Society for the Study of Stress «Stress under control»

ORCID: 0000-0002-3908-0381

Demidova T.Yu.

Pirogov Russian National Research Medical University

ORCID: 0000-0001-9500-5813

Klimenko A.A.

Pirogov Russian National Research Medical University

ORCID: 0000-0002-7410-9784

Kokorin V.A.

Pirogov Russian National Research Medical University

ORCID: 0000-0001-8614-6542

Ostroumova O.D.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 3910-6585
Scopus AuthorID: 7004067629
ResearcherID: M-9553-2014
ORCID: 0000-0002-0795-8225

Ostroumova T.M.

Sechenov First Moscow State Medical University (Sechenov University)

SPIN RSCI: 5043-4713
Scopus AuthorID: 57200081144
ORCID: 0000-0003-1499-247X

Received:

11.03.2024

Accepted:

20.03.2024

Close metadata

References:

American Academy of Sleep Medicine. International classification of sleep disorders. 3d ed. Darien (IL): American Academy of Sleep Medicine; 2014.
Oganov RG, Denisov IN, Simanenkov VI, et al. Comorbidities in practice. Clinical guidelines. Cardiovascular Therapy and Prevention. 2017;16(6):5-56. (In Russ.). https://doi.org/10.15829/1728-8800-2017-6-5-56
Lekarstvenno-indutsirovannye zabolevaniya. Tom I. Eds Sychev D.A., Ostroumova O.D. M.: Prometei; 2022. (In Russ.).
Van Someren EJW. Brain mechanisms of insomnia: new perspectives on causes and consequences. Physiol Rev. 2021;101(3):995-1046. https://doi.org/10.1152/physrev.00046.2019
Barclay NL, Kocevska D, Bramer WM, et al. The heritability of insomnia: A meta-analysis of twin studies. Genes Brain Behav. 2021;20(4):e12717. https://doi.org/10.1111/gbb.12717
Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40(8):869-893. https://doi.org/10.1016/S0005-7967(01)00061-4
Palagini L, Geoffroy PA, Balestrieri M, et al. Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment. J Sleep Res. 2023;32(4):e13825. https://doi.org/10.1111/jsr.13825
Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541-553.
Perlis ML, Ellis JG, Kloss JD, Riemann DW, eds. Principles and Practice of Sleep Medicine. 6th ed. Philadelphia: Elsevier; 2016.
Poluektov MG, Pchelina PV. Chronic insomnia: treatment methods based on the current «3P» model of insomnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(12):141-147. (In Russ.). https://doi.org/10.17116/jnevro2015115112141-147
Dong Y, Yang FM. Insomnia symptoms predict both future hypertension and depression. Prev Med. 2019;123:41-47. https://doi.org/10.1016/j.ypmed.2019.02.001
Palagini L, Bruno RM, Cheng P, et al. Relationship between insomnia symptoms, perceived stress and coping strategies in subjects with arterial hypertension: psychological factors may play a modulating role. Sleep Med. 2016;19:108-115. https://doi.org/10.1016/j.sleep.2015.09.026
Dressle RJ, Riemann D. Hyperarousal in insomnia disorder: Current evidence and potential mechanisms. J Sleep Res. 2023;32(6):e13928. https://doi.org/10.1111/jsr.13928
Kalmbach DA, Anderson JR, Drake CL. The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders. J Sleep Res. 2018;27(6):e12710. https://doi.org/10.1111/jsr.12710
Knutson KL, Van Cauter E, Rathouz PJ, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009;169(11):1055-1061. https://doi.org/10.1001/archinternmed.2009.119
Devine JK, Bertisch SM, Yang H, et al. Glucocorticoid and inflammatory reactivity to a repeated physiological stressor in insomnia disorder. Neurobiol Sleep Circadian Rhythms. 2018;6:77-84. https://doi.org/10.1016/j.nbscr.2018.06.001
Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40-52. https://doi.org/10.1016/j.biopsych.2015.05.014
Budhiraja R, Siddiqi TA, Quan SF. Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med. 2015;11(3):259-270. https://doi.org/10.5664/jcsm.4540
Ostroumova OD, Isaev RI, Pereverzev AP. Drug-induced insomnia in old and very old patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):142-152. (In Russ.). https://doi.org/10.17116/jnevro2019119081142
Khandelwal D, Dutta D, Chittawar S, et al. Sleep Disorders in Type 2 Diabetes. Indian J Endocrinol Metab. 2017;21(5):758-761. https://doi.org/10.4103/ijem.IJEM_156_17
Johnson KA, Gordon CJ, Chapman JL, et al. The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis. Sleep Med Rev. 2021;59:101456. https://doi.org/10.1016/j.smrv.2021.101456
De Baets L, Runge N, Labie C, et al. The interplay between symptoms of insomnia and pain in people with osteoarthritis: A narrative review of the current evidence. Sleep Med Rev. 2023;70:101793. https://doi.org/10.1016/j.smrv.2023.101793
Rogers N, Meng QJ. Tick tock, the cartilage clock. Osteoarthritis Cartilage. 2023;31(11):1425-1436. https://doi.org/10.1016/j.joca.2023.05.010
Odegård SS, Sand T, Engstrøm M, et al. The long-term effect of insomnia on primary headaches: a prospective population-based cohort study (HUNT-2 and HUNT-3). Headache. 2011;51(4):570-580. https://doi.org/10.1111/j.1526-4610.2011.01859.x
Vgontzas A, Cui L, Merikangas KR. Are sleep difficulties associated with migraine attributable to anxiety and depression? Headache. 2008;48(10):1451-1459. https://doi.org/10.1111/j.1526-4610.2008.01175.x
Stanyer EC, Creeney H, Nesbitt AD, et al. Subjective Sleep Quality and Sleep Architecture in Patients With Migraine: A Meta-analysis. Neurology. 2021;97(16):e1620-e1631. https://doi.org/10.1212/WNL.0000000000012701
Simpson NS, Scott-Sutherland J, Gautam S, Sethna N, Haack M. Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization. Pain. 2018;159(1):33-40. https://doi.org/10.1097/j.pain.0000000000001053
Nodel MR, Kovrov GV. Sleep disorders in Parkinson’s disease: approaches to treatment and prevention. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2017;9(4):88-94. (In Russ.). https://doi.org/10.14412/2074-2711-2017-4-88-84
Hepburn M, Bollu PC, French B, Sahota P. Sleep Medicine: Stroke and Sleep. Mo Med. 2018;115(6):527-532.
Amalia L, Garyani MD, Lailiyya N. Increasing of Cortisol Level and Neutrophil-Lymphocyte-Ratio are Associated with Severity Level and Sleep Disturbances in Acute Ischemic Stroke. Int J Gen Med. 2023;16:5439-5448. https://doi.org/10.2147/IJGM.S439149
Gong L, Liao T, Liu D, et al. Changes in Chronic Insomnia and Their Association with Sleep and Anxiety Symptoms: Insight from Shape Analysis. Neural Plast. 2019;2019:8549237. https://doi.org/10.1155/2019/8549237
Asarnow LD. Depression and sleep: what has the treatment research revealed and could the HPA axis be a potential mechanism? Curr Opin Psychol. 2020;34:112-116. https://doi.org/10.1016/j.copsyc.2019.12.002
Pesonen AK, Gradisar M, Kuula L, et al. REM sleep fragmentation associated with depressive symptoms and genetic risk for depression in a community-based sample of adolescents. J Affect Disord. 2019;245:757-763. https://doi.org/10.1016/j.jad.2018.11.077
Wang T, Yan J, Li S, et al. Increased insular connectivity with emotional regions in primary insomnia patients: a resting-state fMRI study. Eur Radiol. 2017;27(9):3703-3709. https://doi.org/10.1007/s00330-016-4680-0
Riemann D, Krone LB, Wulff K, Nissen C. Sleep, insomnia, and depression. Neuropsychopharmacology. 2020;45(1):74-89. https://doi.org/10.1038/s41386-019-0411-y
Rahmani M, Rahmani F, Rezaei N. The Brain-Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression. Neurochem Res. 2020;45(2):221-231. https://doi.org/10.1007/s11064-019-02914-1
Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. https://doi.org/10.1111/jsr.12594
Bochkarev MV, Korostovtseva LS, Filchenko IA, et al. Social-demographic aspects of insomnia in the Russian population according to ESSE-RF study. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(4-2):26-34. (In Russ.). https://doi.org/10.17116/jnevro20181184226
Patel D, Steinberg J, Patel P. Insomnia in the Elderly: A Review. J Clin Sleep Med. 2018;14(6):1017-1024. https://doi.org/10.5664/jcsm.7172
Zeng LN, Zong QQ, Yang Y, et al. Gender Difference in the Prevalence of Insomnia: A Meta-Analysis of Observational Studies. Front Psychiatry. 2020;11:577429. https://doi.org/10.3389/fpsyt.2020.577429
Smith L, Shin JI, Jacob L, et al. Association between physical multimorbidity and sleep problems in 46 low- and middle-income countries. Maturitas. 2022;160:23-31. https://doi.org/10.1016/j.maturitas.2022.01.007
Jarrin DC, Alvaro PK, Bouchard MA, et al. Insomnia and hypertension: A systematic review. Sleep Med Rev. 2018;41:3-38. https://doi.org/10.1016/j.smrv.2018.02.003
Al-Harbi A, Alanazi T, Alghamdi H, et al. Prevalence of insomnia among patients with bronchial asthma. J Asthma Allergy. 2022;15:111-116. https://doi.org/10.2147/JAA.S345086
Sundbom F, Malinovschi A, Lindberg E, et al. Insomnia symptoms and asthma control-Interrelations and importance of comorbidities. Clin Exp Allergy. 2020;50(2):170-177. https://doi.org/10.1111/cea.13517
Du D, Zhang G, Xu D, et al. Prevalence and clinical characteristics of sleep disorders in chronic obstructive pulmonary disease: A systematic review and meta-analysis. Sleep Med. 2023;112:282-290. https://doi.org/10.1016/j.sleep.2023.10.034
Koopman ADM, Beulens JW, Dijkstra T, et al. Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis. J Clin Endocrinol Metab. 2020;105(3):614-643. https://doi.org/10.1210/clinem/dgz065
Lu H, Yang Q, Tian F, et al. A Meta-Analysis of a Cohort Study on the Association between Sleep Duration and Type 2 Diabetes Mellitus. J Diabetes Res. 2021;2021:8861038. https://doi.org/10.1155/2021/8861038
Louie GH, Tektonidou MG, Caban-Martinez AJ, Ward MM. Sleep disturbances in adults with arthritis: prevalence, mediators, and subgroups at greatest risk. Data from the 2007 National Health Interview Survey. Arthritis Care Res (Hoboken). 2011;63(2):247-260. https://doi.org/10.1002/acr.20362
Cho Y, Jung B, Lee YJ, et al. Association between sleep duration and osteoarthritis and their prevalence in Koreans: A cross-sectional study. PLoS One. 2020;15(4):e0230481. https://doi.org/10.1371/journal.pone.0230481
Kim J, Cho SJ, Kim WJ, et al. Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain. 2018;19(1):86. https://doi.org/10.1186/s10194-018-0916-5
Kim J, Cho SJ, Kim WJ, et al. Insufficient sleep is prevalent among migraineurs: a population-based study. J Headache Pain. 2017;18(1):50. https://doi.org/10.1186/s10194-017-0756-8
Maggi G, Vitale C, Cerciello F, Santangelo G. Sleep and wakefulness disturbances in Parkinson’s disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia. Sleep Med Rev. 2023;68:101759. https://doi.org/10.1016/j.smrv.2023.101759
Baylan S, Griffiths S, Grant N, et al. Incidence and prevalence of post-stroke insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2020;49:101222. https://doi.org/10.1016/j.smrv.2019.101222
Hasan F, Gordon C, Wu D, et al. Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis. Stroke. 2022;52(2):655-663. https://doi.org/10.1161/STROKEAHA.120.029847
Alvaro PK, Roberts RM, Harris JK. A Systematic Review Assessing Bidirectionality between Sleep Disturbances, Anxiety, and Depression. Sleep. 2013;36(7):1059-1068. https://doi.org/10.5665/sleep.2810
Singareddy R, Uhde TW. Nocturnal sleep panic and depression: relationship to subjective sleep in panic disorder. J Affect Disord. 2009;112:262-266. https://doi.org/10.1016/j.jad.2008.04.026
Ahmadi R, Rahimi-Jafari S, Olfati M, et al. Insomnia and post-traumatic stress disorder: A meta-analysis on interrelated association (n=57,618) and prevalence (n=573,665). Neurosci Biobehav Rev. 2022;141:104850. https://doi.org/10.1016/j.neubiorev.2022.104850
International Classification of Diseases 10th Revision. https://mkb-10.com
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
Ostroumova TM, Parfenov VA, Ostroumova OD, Kochetkov AI. Hypertension and insomnia. Therapeutic Archive. 2020;92(1):69-75. (In Russ.). https://doi.org/10.26442/00403660.2020.01.000319
Shulman R, Cohen DL, Grandner MA, et al. Sleep duration and 24-hour ambulatory blood pressure in adults not on antihypertensive medications. J Clin Hypertens. 2018;20(12):1712-1720.
Luyster FS, Shi X, Baniak LM, et al. Associations of sleep duration with patient-reported outcomes and health care use in US adults with asthma. Ann Allergy Asthma Immunol. 2020;125(3):319-324. https://doi.org/10.1016/j.anai.2020.04.035
Fu K, Makovey J, Metcalf B, et al. Sleep Quality and Fatigue Are Associated with Pain Exacerbations of Hip Osteoarthritis: An Internet-based Case-crossover Study. J Rheumatol. 2019;46(11):1524-1530. https://doi.org/10.3899/jrheum.181406
Fawzy RM, Abdel-Monem SM, El-Brashi A-WS, et al. A comparative study between rheumatoid arthritis and osteoarthritis regarding association of insomnia with disease status. Egyptian Rheumatol Rehabil. 2022;49:4. https://doi.org/10.1186/s43166-021-00108-8
Glozier N, Moullaali TJ, Sivertsen B, et al. The Course and Impact of Poststroke Insomnia in Stroke Survivors Aged 18 to 65 Years: Results from the Psychosocial Outcomes In StrokE (POISE) Study. Cerebrovasc Dis Extra. 2017;7(1):9-20. https://doi.org/10.1159/000455751
Hale E, Gottlieb E, Usseglio J, Shechter A. Post-stroke sleep disturbance and recurrent cardiovascular and cerebrovascular events: A systematic review and meta-analysis. Sleep Med. 2023;104:29-41. https://doi.org/10.1016/j.sleep.2023.02.019
Ferre Navarrete F, Pérez Páramo M, Fermin Ordoño J, López Gómez V. Prevalence of Insomnia and Associated Factors in Outpatients With Generalized Anxiety Disorder Treated in Psychiatric Clinics. Behav Sleep Med. 2017;15(6):491-501. https://doi.org/10.1080/15402002.2016.1163703
Hong S, Kim S, Park DH, et al. The Mediating Effect of Insomnia on the Relationship between Panic Symptoms and Depression in Patients with Panic Disorder. J Korean Med Sci. 2021;36(9):e30. https://doi.org/10.3346/jkms.2021.36.e30
Carlson GC, Sharifian N, Jacobson IG, et al. Millennium Cohort Study Team. Contribution of post-trauma insomnia to depression and posttraumatic stress disorder in women service members: findings from the Millennium Cohort Study. Sleep. 2023;46(3):zsac313. https://doi.org/10.1093/sleep/zsac313
Khurshid KA. Comorbid insomnia and psychiatric disorders: an update. Innov Clin Neurosci. 2018;15(3-4):28-32. https://pubmed.ncbi.nlm.nih.gov/29707424/
Poluektov MG, Akarachkova ES, Dovgan EV, et al. Management of patients with insomnia and polymorbidity: expert consensus. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5-2):49-57. (In Russ.). https://doi.org/10.17116/jnevro202312305249
Poluektov MG, Buzunov RV, Averbukh VM, et al. Project of clinical recommendations on diagnosis and treatment of chronic insomnia in adults. Consilium Medicum. Neurology and Rheumatology. 2016;2:41-51. (In Russ.).
Korostovtseva LS, Bochkarev MV, Sviryaev YuV. Healthy sleep: subjective vs. objective measures. Effective pharmacotherapy. 2019;15(44):6-14. (In Russ.).
Riemann D, Espie CA, Altena E, et al. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32(6):e14035. https://doi.org/10.1111/jsr.14035
Smith MT, McCrae CS, Cheung J, et al. Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Systematic Review, Meta-Analysis, and GRADE Assessment. J Clin Sleep Med. 2018;14(7):1209-1230. https://doi.org/10.5664/jcsm.7228
Magomedova KA, Poluektov MG. Primenenie aktigrafii dlia vyiavleniia narushenii sna u lits starshikh vozrastnykh grupp. Klinicheskaia gerontologiia. 2014;20(3-4):35-38. (In Russ.).
Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307. https://doi.org/10.1016/s1389-9457(00)00065-4
Dieperink KB, Elnegaard CM, Winther B, et al. Preliminary validation of the insomnia severity index in Danish outpatients with a medical condition. J Patient Rep Outcomes. 2020;4(1):18. https://doi.org/10.1186/s41687-020-0182-6
Gagnon C, Bélanger L, Ivers H, Morin CM. Validation of the Insomnia Severity Index in primary care. J Am Board Fam Med. 2013;26(6):701-710. https://doi.org/10.3122/jabfm.2013.06.130064
De Crescenzo F, D’Alò GL, Ostinelli EG, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022;400(10347):170-184. https://doi.org/10.1016/S0140-6736(22)00878-9
Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307-349. https://doi.org/10.5664/jcsm.6470
Ministerstvo zdravookhraneniya Rossiiskoi federatsii. Metodicheskoe rukovodstvo. Farmakoterapiya u lits pozhilogo i starcheskogo vozrasta. ID: MP103. (In Russ.). Accessed March 14, 2024. https://apicr.minzdrav.gov.ru/Files/recomend/MP103.PDF
Samara MT, Huhn M, Chiocchia V, et al. Efficacy, acceptability, and tolerability of all available treatments for insomnia in the elderly: a systematic review and network meta-analysis. Acta Psychiatr Scand. 2020;142(1):6-17. https://doi.org/10.1111/acps.13201
Marupuru S, Arku D, Campbell AM, et al. Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(17):5138. https://doi.org/10.3390/jcm11175138
Madaeva IM, Shevyrtalova ON, Madaev VV. Primenenie doksilamina pri insomnii u patsientov s arterial’noy gipertenziey. Consilium Medicum. 2009;11(9):69-72. (In Russ.).
Smulevich AB, Zheleznova MV, Pavlova LK. The use of the drug «Donormil» in the treatment of sleep disorders of medium and mild severity in the practice of a psychiatrist. Psikhiatriya i psikhofarmakoterapiya = Psychiatry and Psychopharmacotherapy. 2006;1:12-17. (In Russ.).
Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5(5):CD010753. https://doi.org/10.1002/14651858.CD010753
Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018;45:25-32. https://doi.org/10.1016/j.sleep.2018.01.010
Jaffer KY, Chang T, Vanle B, et al. Trazodone for Insomnia: A Systematic Review. Innov Clin Neurosci. 2017;14(7-8):24-34.
Lin CY, Chiang CH, Tseng MM, et al. Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials. Eur Neuropsychopharmacol. 2023;67:22-36. https://doi.org/10.1016/j.euroneuro.2022.11.008
Hong JSW, Atkinson LZ, Al-Juffali N, et al. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry. 2022;27(3):1339-1349. https://doi.org/10.1038/s41380-021-01386-6
Bollu V, Bushmakin AG, Cappelleri JC, et al. Pregabalin reduces sleep disturbance in patients with generalized anxiety disorder via both direct and indirect mechanisms. Eur J Psychiatry. 2010;24:18-27. https://doi.org/10.4321/S0213-61632010000100003
Leach MJ, Page AT. Herbal medicine for insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2015;24:1-12. https://doi.org/10.1016/j.smrv.2014.12.003
Shinjyo N, Waddell G, Green J. Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and Meta-Analysis. J Evid Based Integr Med. 2020;25:2515690X20967323. https://doi.org/10.1177/2515690X20967323
van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16. https://doi.org/10.1016/j.smrv.2017.02.001
Hertenstein E, Trinca E, Wunderlin M, et al. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: A systematic review and meta-analysis. Sleep Med Rev. 2022;62:101597. https://doi.org/10.1016/j.smrv.2022.101597
Selvanathan J, Pham C, Nagappa M, et al. Cognitive behavioral therapy for insomnia in patients with chronic pain — A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2021;60:101460. https://doi.org/10.1016/j.smrv.2021.101460
Gao Y, Liu M, Yao L, et al. Cognitive behavior therapy for insomnia in cancer patients: a systematic review and network meta-analysis. J Evid Based Med. 2022;15(3):216-229. https://doi.org/10.1111/jebm.12485
Lin HM, Hsieh PS, Chen NC, et al. Impact of cognitive behavior therapy on osteoarthritis-associated pain, insomnia, depression, fatigue, and physical function in patients with knee/hip osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2023;9:1083095. https://doi.org/10.3389/fmed.2022.1083095
Patel S, Ojo O, Genc G, et al. A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD). J Clin Mov Disord. 2017;4:16. https://doi.org/10.1186/s40734-017-0062-2
Smitherman TA, Walters AB, Davis RE, et al. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia. Headache. 2016;56(2):276-291. https://doi.org/10.1111/head.12760
Kapella M, Steffen A, Prasad B, et al. Therapy for insomnia with chronic obstructive pulmonary disease: a randomized trial of components. J Clin Sleep Med. 2022;18(12):2763-2774. https://doi.org/10.5664/jcsm.10210